Patents by Inventor Scott MIX

Scott MIX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11866700
    Abstract: Aspects of the invention relate to antisense oligonucleotides directed to the interleukin 17 receptor (IL-17R), and other targets. Spherical nucleic acid formulations or compositions of antisense oligonucleotides and related methods of treatment are also provided.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: January 9, 2024
    Assignee: Exicure Operating Company
    Inventors: Richard Kang, Scott Mix, Ekambar Kandimalla
  • Publication number: 20200339989
    Abstract: Optimized inhibitory nucleic acids are provided. The nucleic acids have sequences which include an optimal inhibitory motif, such as GGG. Related methods are also described.
    Type: Application
    Filed: May 26, 2020
    Publication date: October 29, 2020
    Applicant: Exicure, Inc.
    Inventors: Weston Daniel, Scott Mix
  • Patent number: 10704043
    Abstract: Optimized inhibitory nucleic acids are provided. The nucleic acids have sequences which include an optimal inhibitory motif, such as a GGG. Related methods are also described.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: July 7, 2020
    Assignee: Exicure, Inc.
    Inventors: Weston Daniel, Scott Mix
  • Publication number: 20180327741
    Abstract: Optimized inhibitory nucleic acids are provided. The nucleic acids have sequences which include an optimal inhibitory motif, such as a GGG. Related methods are also described.
    Type: Application
    Filed: January 14, 2016
    Publication date: November 15, 2018
    Applicant: Exicure, Inc.
    Inventors: Weston DANIEL, Scott MIX